Dysregulation of the Akt/mTOR signaling pathway has been associated with AD pathology in both in vivo animal models of AD and in postmortem brain tissues from AD patients (21, 42, 69, 70, 71). The gene discussed is MTOR; the disease is Alzheimer disease.